Mogi M - Search Results

1

Effects of systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to mice on tyrosine hydroxylase, L-3,4-dihydroxyphenylalanine decarboxylase, dopamine beta-hydroxylase, and monoamine oxidase activities in the striatum and hypothalamus.

Mogi M, Harada M, Kojima K, Kiuchi K, Nagatsu T. Mogi M, et al. J Neurochem. 1988 Apr;50(4):1053-6. doi: 10.1111/j.1471-4159.1988.tb10572.x. J Neurochem. 1988. PMID: 2894407

2

Purification and immunochemical properties of tyrosine hydroxylase in human brain.

Mogi M, Kojima K, Harada M, Nagatsu T. Mogi M, et al. Neurochem Int. 1986;8(3):423-8. doi: 10.1016/0197-0186(86)90017-3. Neurochem Int. 1986. PMID: 20493073

3

Sandwich enzyme immunoassay of dopamine-?-hydroxylase in cerebrospinal fluid from control and parkinsonian patients.

Mogi M, Harada M, Kojima K, Inagaki H, Kondo T, Narabayashi H, Arai T, Teradaira R, Fujita K, Kiuchi K, Nagatsu T. Mogi M, et al. Neurochem Int. 1988;12(2):187-91. doi: 10.1016/0197-0186(88)90126-x. Neurochem Int. 1988. PMID: 20501220

4

Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration in prenatal stage on the dopamine system in the postnatal mouse brain.

Ochi N, Naoi M, Mogi M, Ohya Y, Mizutani N, Watanabe K, Harada M, Nagatsu T. Ochi N, et al. Among authors: mogi m. Life Sci. 1991;48(3):217-23. doi: 10.1016/0024-3205(91)90348-f. Life Sci. 1991. PMID: 1671518

5

Effects of repeated systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal tyrosine hydroxylase activity in vitro and tyrosine hydroxylase content.

Mogi M, Harada M, Kojima K, Kiuchi K, Nagatsu I, Nagatsu T. Mogi M, et al. Neurosci Lett. 1987 Sep 23;80(2):213-8. doi: 10.1016/0304-3940(87)90656-2. Neurosci Lett. 1987. PMID: 2891089

6

Inactivation of tyrosine hydroxylase in rat striatum by 1-methyl-4-phenylpyridinium ion (MPP+).

Ozaki N, Nakahara D, Mogi M, Harada M, Kiuchi K, Kaneda N, Miura Y, Kasahara Y, Nagatsu T. Ozaki N, et al. Among authors: mogi m. Neurosci Lett. 1988 Feb 29;85(2):228-32. doi: 10.1016/0304-3940(88)90356-4. Neurosci Lett. 1988. PMID: 2897647

7

Homospecific activity (activity per enzyme protein) of tyrosine hydroxylase increases in parkinsonian brain.

Mogi M, Harada M, Kiuchi K, Kojima K, Kondo T, Narabayashi H, Rausch D, Riederer P, Jellinger K, Nagatsu T. Mogi M, et al. J Neural Transm. 1988;72(1):77-82. doi: 10.1007/BF01244634. J Neural Transm. 1988. PMID: 2897999

8

Brain beta 2-microglobulin levels are elevated in the striatum in Parkinson's disease.

Mogi M, Harada M, Kondo T, Riederer P, Nagatsu T. Mogi M, et al. J Neural Transm Park Dis Dement Sect. 1995;9(1):87-92. doi: 10.1007/BF02252965. J Neural Transm Park Dis Dement Sect. 1995. PMID: 7605592

9

Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients.

Mogi M, Harada M, Riederer P, Narabayashi H, Fujita K, Nagatsu T. Mogi M, et al. Neurosci Lett. 1994 Jan 3;165(1-2):208-10. doi: 10.1016/0304-3940(94)90746-3. Neurosci Lett. 1994. PMID: 8015728

10

Interleukin-2 but not basic fibroblast growth factor is elevated in parkinsonian brain. Short communication.

Mogi M, Harada M, Kondo T, Riederer P, Nagatsu T. Mogi M, et al. J Neural Transm (Vienna). 1996;103(8-9):1077-81. doi: 10.1007/BF01291792. J Neural Transm (Vienna). 1996. PMID: 9013395

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

557 results

Search Page

Filters